triiodothyronine has been researched along with furosemide in 26 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (30.77) | 18.7374 |
1990's | 7 (26.92) | 18.2507 |
2000's | 4 (15.38) | 29.6817 |
2010's | 7 (26.92) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Strassburg, CP; Tukey, RH | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Aleo, MD; Bonin, PD; Luo, Y; Potter, DM; Swiss, R; Will, Y | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Bolognesi, F; Cocco, R; Giusti, M; Marugo, M; Reitano, A | 1 |
Kucher, E | 1 |
Barlow, JW; Lim, CF; Raggatt, LE; Stockigt, JR; Topliss, DJ | 1 |
Chu, SH; Hsu, RB; Huang, TS; Wang, CJ; Wang, SS | 1 |
Green, B; Groskopf, W; Hsu, S; Sohn, L | 1 |
Barlow, JW; Hamblin, PS; Lim, CF; Mohr, VS; Sabto, J; Stockigt, JR; Topliss, DJ; Wynne, KN | 1 |
Barton, CI; Chaffin, J; Cooper, DK; Greer, A; Grim, J; Novitzky, D; Zuhdi, N | 1 |
Haber, RS; Ismail-Beigi, F; Loeb, JN | 1 |
Hamblin, PS; Lim, CF; Long, F; Newnham, HH; Stockigt, JR; Topliss, DJ | 1 |
Baggenstoss, AH; Fudenberg, HH; Kyle, RA; Maldonado, JE; McNutt, DR | 1 |
Akiba, H; Demura, H; Koike, S; Kurihara, S; Kusakabe, K | 1 |
Kennedy, JA; Lim, CF; Loidl, NM; Stokigt, JR; Topliss, DJ | 1 |
Barlow, JW; Curtis, AJ; Loidl, NM; Raggatt, LE; Stockigt, JR; Topliss, DJ | 1 |
Barlow, JW; Curtis, AJ; Lim, CF; Stockigt, JR; Topliss, DJ; Wynne, KN | 1 |
Asmah, BJ; Khalid, BA; Norazmi, K; Tan, TT; Wan Nazaimoon, WM | 1 |
Karapitta, CD; Papadimitriou, A; Sotiroudis, TG; Xenakis, A | 1 |
Camphausen, CK; Haas, NA | 1 |
Lim, CF; Stockigt, JR | 1 |
3 review(s) available for triiodothyronine and furosemide
Article | Year |
---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Medications that distort in vitro tests of thyroid function, with particular reference to estimates of serum free thyroxine.
Topics: Antibodies, Heterophile; Artifacts; Diagnostic Errors; Drug Stability; Fatty Acids, Nonesterified; Furosemide; Humans; Specimen Handling; Thyroid Function Tests; Thyrotropin; Thyroxine; Thyroxine-Binding Globulin; Triiodothyronine | 2009 |
1 trial(s) available for triiodothyronine and furosemide
Article | Year |
---|---|
Triiodothyronine as an inotropic agent after open heart surgery.
Topics: Cardiac Output; Cardiopulmonary Bypass; Coronary Artery Bypass; Furosemide; Humans; Myocardial Contraction; Randomized Controlled Trials as Topic; Stroke Volume; Time Factors; Triiodothyronine; Vascular Resistance | 1989 |
22 other study(ies) available for triiodothyronine and furosemide
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Human drug-induced liver injury severity is highly associated with dual inhibition of liver mitochondrial function and bile salt export pump.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Chemical and Drug Induced Liver Injury; Humans; Male; Mitochondria, Liver; Rats; Rats, Sprague-Dawley; Severity of Illness Index | 2014 |
[Diazoxide in the treatment of obesity].
Topics: Diazoxide; Dietary Proteins; Fenfluramine; Furosemide; Glucagon; Humans; Obesity; Triiodothyronine | 1977 |
[Indications and results of an additional differentiated pharmacotherapy of obesity].
Topics: Adolescent; Adult; Aged; Biguanides; Diabetes Mellitus; Diet, Reducing; Female; Furosemide; Humans; Hydrochlorothiazide; Hyperlipidemias; Hypertension; Male; Middle Aged; Obesity; Triiodothyronine | 1978 |
Characterization of cytoplasmic T3 binding sites by adsorption to hydroxyapatite: effects of drug inhibitors of T3 and relationship to glutathione-S-transferases.
Topics: Amiodarone; Animals; Binding Sites; Binding, Competitive; Cytosol; Diclofenac; Dithiothreitol; Dose-Response Relationship, Drug; Durapatite; Furosemide; Glutathione Transferase; Hydrocortisone; Hydroxyapatites; In Vitro Techniques; Iopanoic Acid; Liver; Macaca fascicularis; Mefenamic Acid; Sulfobromophthalein; Taurocholic Acid; Triiodothyronine | 1992 |
Thyroid hormone changes after cardiovascular surgery and clinical implications.
Topics: Aged; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Catecholamines; Female; Furosemide; Humans; Male; Middle Aged; Postoperative Complications; Prognosis; Prospective Studies; Thyroid Function Tests; Thyroid Hormones; Thyrotropin; Thyroxine; Triiodothyronine; Vascular Surgical Procedures | 1991 |
Furosemide as a displacing agent in assay of total triiodothyronine.
Topics: Drug Interactions; Furosemide; Humans; Radioimmunoassay; Triiodothyronine | 1991 |
Interaction of furosemide with serum thyroxine-binding sites: in vivo and in vitro studies and comparison with other inhibitors.
Topics: Binding, Competitive; Charcoal; Dextrans; Dialysis; Furosemide; Humans; In Vitro Techniques; Kidney Diseases; Kinetics; Ligands; Peritoneal Dialysis; Prealbumin; Receptors, Cell Surface; Receptors, Thyroid Hormone; Serum Albumin; Thyroxine; Thyroxine-Binding Proteins; Triiodothyronine | 1985 |
Stimulation of active Na+ and K+ transport by thyroid hormone in a rat liver cell line: role of enhanced Na+ entry.
Topics: Animals; Biological Transport, Active; Cell Line; Cell Membrane Permeability; Furosemide; Liver; Monensin; Ouabain; Potassium; Rats; Sodium; Sodium-Potassium-Exchanging ATPase; Triiodothyronine | 1986 |
Effect of oral frusemide on diagnostic indices of thyroid function.
Topics: Administration, Oral; Furosemide; Heart Failure; Humans; Thyroid Function Tests; Thyroid Gland; Thyrotropin; Thyroxine; Time Factors; Triiodothyronine | 1987 |
IgG cryoglobulinemia associated with amyloidosis.
Topics: Amyloidosis; Autoantibodies; Blood Protein Disorders; Bone Marrow Examination; Chlorambucil; Cryoglobulins; Female; Furosemide; Humans; Hypothyroidism; Immunoglobulin G; Middle Aged; Plasmapheresis; Prednisone; Triiodothyronine | 1973 |
[Experimental observation of Triosorb-S kit and influence of drugs (author's transl)].
Topics: Evaluation Studies as Topic; Furosemide; Humans; Indomethacin; Reagent Kits, Diagnostic; Thyroid Function Tests; Triiodothyronine | 1981 |
Effect of loop diuretics and nonsteroidal antiinflammatory drugs on thyrotropin release by rat anterior pituitary cells in vitro.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cells, Cultured; Diuretics; Dose-Response Relationship, Drug; Furosemide; Male; Meclofenamic Acid; Phenylacetates; Phenytoin; Pituitary Gland, Anterior; Rats; Rats, Wistar; Thyrotropin; Thyrotropin-Releasing Hormone; Triiodothyronine | 1995 |
Drug competition for intracellular triiodothyronine-binding sites.
Topics: Amiodarone; Animals; Anti-Inflammatory Agents, Non-Steroidal; Binding Sites; Binding, Competitive; Carcinoma, Hepatocellular; Fatty Acids, Nonesterified; Flavonoids; Furosemide; Humans; Iodide Peroxidase; Liver; Liver Neoplasms; Macaca fascicularis; Sex Hormone-Binding Globulin; Sulfobromophthalein; Triiodothyronine; Tumor Cells, Cultured | 1994 |
A naturally occurring furan fatty acid enhances drug inhibition of thyroxine binding in serum.
Topics: Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Binding, Competitive; Diflunisal; Dose-Response Relationship, Drug; Drug Interactions; Fatty Acids, Nonesterified; Furans; Furosemide; Humans; Oleic Acid; Oleic Acids; Phenylacetates; Prealbumin; Propionates; Thyroxine; Thyroxine-Binding Proteins; Triiodothyronine | 1993 |
Plasma renin and aldosterone in thyroid diseases.
Topics: Aldosterone; Cross-Sectional Studies; Diuretics; Furosemide; Humans; Hypothyroidism; Potassium; Renin; Sodium; Thyroid Diseases; Thyrotoxicosis; Thyrotropin; Thyroxine; Triiodothyronine | 1997 |
Homogeneous enzyme immunoassay for triiodothyronine in serum.
Topics: Adult; Aged; Animals; Binding Sites; Blood Proteins; Female; Fluorometry; Furosemide; Humans; Immunoenzyme Techniques; Indicators and Reagents; Isoenzymes; Male; Maleimides; Middle Aged; Phosphorylases; Rabbits; Radioimmunoassay; Triiodothyronine | 2001 |
Fenoldapam after pediatric cardiac surgery: what is conventional diuretic therapy?
Topics: Aminophylline; Diuretics; Dopamine Agonists; Drug Therapy, Combination; Fenoldopam; Furosemide; Heart Defects, Congenital; Humans; Infant, Newborn; Peritoneal Dialysis; Postoperative Care; Triiodothyronine; Water-Electrolyte Imbalance | 2006 |